Bosuvi (Bosutinib)

Bosuvi (Bosutinib) – Targeted Therapy for Chronic Myeloid Leukaemia

Bosuvi is a prescribed medication with an active substance Bosutinib, which is a targeted cancer treatment that is used to treat some forms of chronic myeloid leukemia (CML). It was developed to provide a specific treatment for cancerous cells. Bosuvi blocks abnormal proteins that encourage the growth of cancer. It is a crucial choice for Australian patients with CML, especially when other treatment options aren’t effective or are not tolerated.

What Is Bosuvi?

Bosuvi is a tyrosine inhibitor (TKI) created to block the BCR-ABL protein. It is a major factor in the progression and development of chronic leukaemia. Through blocking the protein, Bosuvi stops the proliferation of malignant white blood cells, aiding in the control of the illness and improving outcomes.

Accepted by adult patients suffering from recently diagnosed Philadelphia Chromosome-positive (Ph+) CML or those who are resistant or intolerant to previous treatments for TKI, Bosuvi offers an important choice for personalised treatment of cancer.

How Does Bosuvi Work?

Bosutinib, which is the active compound found in Bosuvi, is a drug that blocks the abnormal enzyme tyrosine kinase created through the Philadelphia chromosome within CML. The enzyme is responsible for signaling leukaemic cells to expand in uncontrolled ways. Through binding and preventing the activity of this enzyme, Bosuvi blocks cancer cells from growing and allows healthy cells in the body to perform more efficiently.

This specific mechanism means Bosuvi will attack cancer cells in particular, while also limiting the harm to healthy tissues. An important advantage over conventional chemotherapy.

When Is Bosuvi Prescribed?

Bosuvi is typically prescribed for:

• Adult patients diagnosed as having newly discovered Philadelphia CML with a positive chromosome in the chronic phase
• Patients with CML who are resistant or intolerant to prior tyrosine kinase inhibitor treatment
• Patients who require a second-line treatment or other therapy option

Because of its specialization, Bosuvi is prescribed and examined by oncologists and hematologists skilled in treating blood cancers.

How to Take Bosuvi

• Bosuvi is a tablet for oral use, normally taken every day in conjunction with food, to aid the absorption of food and decrease stomach irritation.
• Tablets are best swallowed whole, with water. Do not chew or crush them.
• The precise dosage is contingent upon the condition of the patient and on the doctor’s prescription.
• A regular schedule of blood tests and health check-ups is necessary for monitoring the effectiveness of medications and their effects.
• The patient should inform the doctor of any other medications or supplements in order to prevent interactions.

Benefits of Bosuvi

• Blocks the BCR-ABL protein responsible for CML development
• Oral treatments for ease of administration, as compared to intravenous treatments
• This is a great option for patients who are not tolerant of TKIs.
• Aids in achieving remission and controlling CML symptoms.
• Increases quality of life by slowing the progression of diseases

Potential Side Effects

Like any other cancer treatment, Bosuvi may cause adverse effects. The most common ones are:

• Diarrhoea, nausea, and vomiting
• Fatigue and weakness
• Rash or skin reactions
• Liver function abnormalities (monitored via blood tests)
• Fluid retention or swelling
• Low blood counts (anaemia, neutropenia, thrombocytopenia)

The majority of side effects can be managed under the supervision of a medical professional. It’s important to note any symptoms that are unusual promptly.

Important Precautions

• Bosuvi could interfere with other drugs like antibiotics, antifungals, and heart medication. Be sure to provide your complete medication list to your physician.
• Do not drink grapefruit juice or grapefruit when using Bosuvi because they may influence the drug levels within your body.
• The use of breastfeeding and pregnancy is both a contraindication and an effective contraception, and it is advised for the course of treatment.
• It is important to inform your physician of any existing health conditions affecting the heart or liver.

Bosuvi Compared to Other TKIs

Frequently Asked Questions About Bosuvi (Bosutinib)

What type of leukaemia does Bosuvi treat?

Bosuvi treats chronic myeloid leukemia (CML) specifically, Philadelphia-positive chromosomes.

How does Bosuvi work to control CML?

It blocks BCR-ABL’s TK enzyme, which is the cause of an abnormally high growth rate of leukaemic cell.

Can Bosuvi cure CML?

Bosuvi aids in controlling and managing CML and is often successful in achieving remission. Although it’s not a cure, it greatly prolongs longevity and increases health.

How should Bosuvi be taken?

Consume Bosuvi every day orally in conjunction with a meal, in the manner prescribed by your doctor.

What are common side effects of Bosuvi?

Nausea, vomiting, diarrhea, itching, and liver changes are some of the most frequent side effects.

Can I drink alcohol while taking Bosuvi?

Avoid drinking alcohol since it could cause increased strain on your liver, particularly when you are taking drugs that can affect the liver’s function.

Is Bosuvi safe during pregnancy?

No, it is not advised during breastfeeding or pregnancy. Consider contraceptive options with your physician.

How often will I need check-ups while on Bosuvi?

A regular blood test and physician visits are crucial to keep track of the response of your body and any side effects, which are usually scheduled every few weeks in the beginning.

What should I do if I miss a dose?

Do the missed dose whenever you remember or if it’s near your next dose. Don’t double-dose.

Can Bosuvi interact with other medications?

Yes, Absolutely, Bosuvi is a drug that interacts with many drugs, like antifungals and heart medicine. Make sure you inform your physician of any medications you are taking.